IL139589A0 - Use of cyclosporins in the treatment of inflammatory autoimmune diseases - Google Patents

Use of cyclosporins in the treatment of inflammatory autoimmune diseases

Info

Publication number: IL139589A0
Authority: IL; Israel
Prior art keywords: cyclosporins; treatment; autoimmune diseases; inflammatory autoimmune; inflammatory
Prior art date: 1998-06-02

Application number

IL13958999A

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-02

Filing date

1999-05-31

Publication date

2002-02-10

1999-05-31 Application filed by Novartis Ag filed Critical Novartis Ag

2002-02-10 Publication of IL139589A0 publication Critical patent/IL139589A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Immunology (AREA)
Neurology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

IL13958999A 1998-06-02 1999-05-31 Use of cyclosporins in the treatment of inflammatory autoimmune diseases IL139589A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9811854.0A GB9811854D0 (en)	1998-06-02	1998-06-02	Organic compounds
PCT/EP1999/003770 WO1999062540A1 (en)	1998-06-02	1999-05-31	Use of cyclosporins in the treatment of inflammatory autoimmune diseases

Publications (1)

Publication Number	Publication Date
IL139589A0 true IL139589A0 (en)	2002-02-10

Family

ID=10833083

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13958999A IL139589A0 (en)	1998-06-02	1999-05-31	Use of cyclosporins in the treatment of inflammatory autoimmune diseases

Country Status (17)

Country	Link
EP (1)	EP1082130A1 (en)
JP (2)	JP4523154B2 (en)
KR (1)	KR20010043969A (en)
CN (1)	CN1304315A (en)
AU (1)	AU750422B2 (en)
BR (1)	BR9910860A (en)
CA (1)	CA2333315A1 (en)
GB (1)	GB9811854D0 (en)
HU (1)	HUP0102142A3 (en)
ID (1)	ID27576A (en)
IL (1)	IL139589A0 (en)
NO (1)	NO20006113L (en)
PL (1)	PL344451A1 (en)
SK (1)	SK18142000A3 (en)
TW (2)	TWI250022B (en)
WO (1)	WO1999062540A1 (en)
ZA (1)	ZA200006464B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2243314T3 (en)	1999-10-27	2005-12-01	Alexandra Lucas	COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF TRANSPLANTATION REJECTION.
EP1365798B1 (en) *	2000-09-29	2009-12-30	Viron Therapeutics, Inc.	Use of serp-1 in combination with an immunosuppressant for treating arthritis
GB0320638D0 (en) *	2003-09-03	2003-10-01	Novartis Ag	Organic compounds
AU2005230400A1 (en) *	2004-04-08	2005-10-20	Novartis Ag	Use of cyclosporins for treatment of cerebral ischemia and brain and spinal cord injury
WO2006005610A1 (en)	2004-07-14	2006-01-19	Novartis Ag	Use of a combination of cyclosporine and pegylated interferon for treating hepatitis c (hcv)
AU2005290984B2 (en) *	2004-10-01	2010-09-09	Debiopharm Sa	Use of [D-MeAla]3-[EtVal]4-cyclosporin for the treatment of hepatitis C infection and pharmaceutical composition comprising said [D-MeAla]3-[EtVal]4-cyclosporin
US7285530B2 (en)	2004-10-21	2007-10-23	Viron Therapeutics, Inc.	Use of SERP-1 as an antiplatelet agent
AU2005322242B2 (en) *	2004-12-23	2010-02-11	Novartis Ag	Compositions for HCV treatment
CA2587586A1 (en) *	2004-12-23	2006-07-06	Novartis Ag	Compounds for flaviviridae treatment
AU2006259348B2 (en) *	2005-06-17	2010-07-22	Novartis Ag	Use of sanglifehrin in HCV
JP2007112775A (en) *	2005-10-24	2007-05-10	Hamamatsu Univ School Of Medicine	Use of cyclosporines in treatment of cytomegalovirus infection
JP5820722B2 (en) *	2008-06-06	2015-11-24	スシネキスインク	Cyclosporine analogues and their use in the treatment of HCV infection
US20090306033A1 (en) *	2008-06-06	2009-12-10	Keqiang Li	Novel cyclic peptides
EP2376524B1 (en)	2008-12-31	2017-03-15	Cypralis Limited	Derivatives of cyclosporin a
JP2013513595A (en) *	2009-12-09	2013-04-22	サイネクシス，インコーポレーテッド	Novel cyclic peptide
CN104603146B (en)	2012-09-29	2018-01-02	诺华股份有限公司	Cyclic peptide compound and its purposes as medicine
WO2014063147A1 (en) *	2012-10-19	2014-04-24	Scynexis, Inc.	New antiviral macrocycles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE148469T1 (en) *	1990-11-02	1997-02-15	Sandoz Ag	CYCLOSPORINS
US6124453A (en) *	1995-07-04	2000-09-26	Novartis Ag	Macrolides
AR006514A1 (en) *	1995-07-04	1999-09-08	Sandoz Ag	A MACROLID, ITS USES, A PROCESS TO PRODUCE IT, A BIOLOGICALLY PURE ISOLATE CAPABLE OF PRODUCING IT, AND A PHARMACEUTICAL COMPOSITION THAT IT INCLUDES
CZ288631B6 (en) *	1996-01-18	2001-08-15	Galena, A. S.	Therapeutic preparations containing cyclosporin
CZ288739B6 (en) *	1996-08-01	2001-08-15	Galena, A. S.	Cyclosporin containing medicinal preparations

1998
- 1998-06-02 GB GBGB9811854.0A patent/GB9811854D0/en not_active Ceased
1999
- 1999-05-31 KR KR1020007013585A patent/KR20010043969A/en not_active Application Discontinuation
- 1999-05-31 CA CA002333315A patent/CA2333315A1/en not_active Abandoned
- 1999-05-31 SK SK1814-2000A patent/SK18142000A3/en unknown
- 1999-05-31 AU AU43724/99A patent/AU750422B2/en not_active Ceased
- 1999-05-31 JP JP2000551796A patent/JP4523154B2/en not_active Expired - Fee Related
- 1999-05-31 CN CN99806904A patent/CN1304315A/en active Pending
- 1999-05-31 EP EP99926489A patent/EP1082130A1/en not_active Withdrawn
- 1999-05-31 PL PL99344451A patent/PL344451A1/en not_active Application Discontinuation
- 1999-05-31 IL IL13958999A patent/IL139589A0/en unknown
- 1999-05-31 HU HU0102142A patent/HUP0102142A3/en unknown
- 1999-05-31 WO PCT/EP1999/003770 patent/WO1999062540A1/en not_active Application Discontinuation
- 1999-05-31 ID IDW20002433A patent/ID27576A/en unknown
- 1999-05-31 BR BR9910860-7A patent/BR9910860A/en not_active IP Right Cessation
- 1999-06-01 TW TW088109078A patent/TWI250022B/en not_active IP Right Cessation
- 1999-06-01 TW TW094110378A patent/TWI250021B/en not_active IP Right Cessation
2000
- 2000-11-09 ZA ZA200006464A patent/ZA200006464B/en unknown
- 2000-12-01 NO NO20006113A patent/NO20006113L/en not_active Application Discontinuation
2009
- 2009-11-04 JP JP2009252882A patent/JP2010059177A/en active Pending

Also Published As

Publication number	Publication date
CN1304315A (en)	2001-07-18
JP2002516873A (en)	2002-06-11
JP4523154B2 (en)	2010-08-11
PL344451A1 (en)	2001-11-05
EP1082130A1 (en)	2001-03-14
WO1999062540A1 (en)	1999-12-09
HUP0102142A3 (en)	2001-12-28
NO20006113D0 (en)	2000-12-01
KR20010043969A (en)	2001-05-25
GB9811854D0 (en)	1998-07-29
ZA200006464B (en)	2002-03-11
HUP0102142A2 (en)	2001-11-28
NO20006113L (en)	2001-01-25
JP2010059177A (en)	2010-03-18
TWI250021B (en)	2006-03-01
AU4372499A (en)	1999-12-20
SK18142000A3 (en)	2001-06-11
CA2333315A1 (en)	1999-12-09
BR9910860A (en)	2001-03-06
ID27576A (en)	2001-04-12
AU750422B2 (en)	2002-07-18
TWI250022B (en)	2006-03-01
TW200522975A (en)	2005-07-16

Publication	Publication Date	Title
ZA983452B (en)	1999-10-25	Substituted pyrrolopyridines useful in the treatment of inflammatory diseases.
IL132318A0 (en)	2001-03-19	Substituted imidazoles useful in the treatment of inflammatory diseases
IL142908A0 (en)	2002-04-21	Compounds useful in the treatment of inflammatory diseases
IL133766A0 (en)	2001-04-30	2-substituted imidazoles useful in the treatment of inflammatory diseases
HUP0102142A3 (en)	2001-12-28	Use of cyclosporins in the treatment of inflammatory autoimmune diseases
PL362984A1 (en)	2004-11-15	Compounds useful in the treatment of inflammatory diseases
IL144981A0 (en)	2002-06-30	Treatment of autoimmune disease
IL131025A0 (en)	2001-01-28	Treatment of autoimmune disease using tolerization in combination with methotrexate
IL148401A0 (en)	2002-09-12	Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases
HK1038601A1 (en)	2002-03-22	Human body cleaner.
ZA984174B (en)	1998-11-23	Novel triptolide derivatives useful in the treatment of autoimmune diseases
SI1326628T1 (en)	2004-10-31	Chemokine mutants in the treatment of multiple sclerosis
HK1025954A1 (en)	2000-12-01	Triptolide derivatives useful in the treatment of autoimmune diseases
IL155174A0 (en)	2003-10-31	Methods and compositions for the treatment of inflammatory diseases
EP1079764A4 (en)	2001-09-12	The treatment of sexual dysfunction in certain patient groups
IL129024A0 (en)	2000-02-17	Use of proteins as agent against autoimmune diseases
GB9927757D0 (en)	2000-01-26	Treatment of autoimmune diseases
HUP0200354A3 (en)	2003-03-28	Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
HUP0200552A2 (en)	2002-06-29	Use of apoptosis inducing agents in the treatment of (auto)immune diseases
IL140825A0 (en)	2002-02-10	Peptides for use in immunotherapy of autoimmune diseases
GB9603657D0 (en)	1996-04-17	Improvements in the treatment of vaginal infections
SI0983275T1 (en)	2002-12-31	Novel triptolide derivatives useful in the treatment of autoimmune diseases
AU2002300624A1 (en)	2003-02-13	Substituted imidazoles useful in the treatment of inflammatory diseases
SI0966447T1 (en)	2003-08-31	Small molecules useful in the treatment of inflammatory disease
ZA978363B (en)	1998-04-01	Use of proteins as agents against autoimmune diseases.